Yokohama, Japan

Mayumi Makino

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Asahi Glass Company, Limited. Active years: 1996-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mayumi Makino. Retrieved from https://idiyas.com/inventor/mayumi-makino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1996-1998

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mayumi Makino: Innovator in Pharmaceutical Chemistry

Introduction

Mayumi Makino is a distinguished inventor based in Yokohama, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. With a total of 3 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Her latest patents include innovative formulations of difluoroprostacyclins. These compounds are characterized by their unique chemical structures, which include various alkyl and alkenyl groups. The patents detail methods for producing these difluoroprostacyclins and their intermediates, showcasing her expertise in synthetic chemistry.

Career Highlights

Mayumi Makino is currently employed at Asahi Glass Company, Limited, where she continues to push the boundaries of pharmaceutical research. Her work has not only advanced the understanding of difluoroprostacyclins but has also opened new avenues for therapeutic applications.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Yasushi Matsumura and Takashi Nakano. These partnerships have enriched her research and contributed to the success of her projects.

Conclusion

Mayumi Makino stands out as a prominent figure in the field of pharmaceutical innovation. Her contributions through her patents and collaborations reflect her dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…